ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00116935
Recruitment Status : Completed
First Posted : July 1, 2005
Last Update Posted : December 30, 2011
Sponsor:
Information provided by (Responsible Party):
Scandinavian Sarcoma Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2010
  Actual Study Completion Date : December 2010
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):